Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Relevance of the Blood-brain Barrier to Cognitive Dysfunction and Alzheimer's Disease

NCT04093882 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.

NCT NCT04093882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04093882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Relevance of the Blood-brain Barrier to Cognitive Dysfunction and Alzheimer's Disease
Lead sponsor
Charite University, Berlin, Germany
Phase
Observational
Overall status
Completed
Start date
September 12, 2019
Completion date
September 30, 2021
Enrollment
101 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, blood brain barrier, cognitive dysfunction, dementia